MDxHealth (MDXH) Receivables - Other (2025)

MDxHealth has reported Receivables - Other for 6 years, with the latest figure at -$18.9 billion in Q2 2025.

• Quarterly Receivables - Other changed N/A year-over-year to -$18.9 billion in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$18.9 billion (changed N/A YoY) and the FY2025 annual result came in at -$18.9 billion, changed N/A from the prior year.
• Receivables - Other declined to -$18.9 billion in Q2 2025 per MDXH's latest filing, from -$13.9 million in the prior quarter.
• Over five years, Receivables - Other peaked at $9.4 million in Q4 2022 and troughed at -$18.9 billion in Q2 2025.
• A 5-year average of -$3.8 billion and a median of $36000.0 in 2023 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2022 and 2024: Receivables - Other jumped 104.21% in 2022, then tumbled 38622.22% in 2024.
• Over 5 years, Receivables - Other stood at $4.6 million in 2021, then surged by 104.21% to $9.4 million in 2022, then slumped by 99.62% to $36000.0 in 2023, then sank by 38622.22% to -$13.9 million in 2024, then tumbled by 136514.93% to -$18.9 billion in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered -$18.9 billion, -$13.9 million, and $36000.0 for Q2 2025, Q4 2024, and Q4 2023 respectively.